Cai S X, Zhang H Z, Guastella J, Drewe J, Yang W, Weber E
Maxim Pharmaceuticals, San Diego, CA 92121, USA.
Bioorg Med Chem Lett. 2001 Jan 8;11(1):39-42. doi: 10.1016/s0960-894x(00)00590-4.
N-Octyloxycarbonyl-R110 (1), with enhanced cell penetration and retention properties, was prepared from rhodamine 110. The tetrapeptide substrate N-Ac-DEVD-N'-octyloxycarbonyl-R110 (3) was prepared and shown to be efficiently cleaved by human recombinant caspase-3 and by apoptotic HL-60 cells. This substrate should prove useful in cell-based assays for apoptosis inducers and inhibitors.